PULSENMORE LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 324.7 ILa | -3.02% |
|
+5.42% | -54.32% |
| 28/03 | Pulsenmore Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 13/03 | Pulsenmore Ltd. Expanding the Application of Its Home Ultrasound Solution for Pregnant Women | CI |
| Sales 2022 | 10.81 4.01K 902.21 | Sales 2023 | 6.19 2.29K 516.26 | Capitalization | 355M 131B 29.6B |
|---|---|---|---|---|---|
| Net income 2022 | -22M -8.15B -1.84B | Net income 2023 | -58M -21.49B -4.84B | EV / Sales 2022 | 1,77,06,058 x |
| Net cash position 2022 | 179M 66.4B 14.95B | Net cash position 2023 | 138M 51.27B 11.55B | EV / Sales 2023 | 3,49,74,785 x |
| P/E ratio 2022 |
-17.4
x | P/E ratio 2023 |
-6.22
x | Employees | 67 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 50.09% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.02% | ||
| 1 week | +5.42% | ||
| Current month | +5.42% | ||
| 1 month | -21.80% | ||
| 3 months | -43.35% | ||
| 6 months | -46.28% | ||
| Current year | -54.32% |
1 week
299.40
334.80
1 month
299.40434.40
Current year
299.40750.00
1 year
299.40894.90
3 years
299.402 000.00
5 years
299.402 000.00
10 years
299.402 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 61 | 27/14/27 | |
Shai Shemesh
DFI | Director of Finance/CFO | 44 | 01/23/01 |
Dan Gus
COO | Chief Operating Officer | - | 01/22/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jonathan Adereth
CHM | Chairman | 77 | 24/20/24 |
Yuval Yanai
BRD | Director/Board Member | 71 | 01/20/01 |
Anat Loewenstein
BRD | Director/Board Member | 64 | 10/21/10 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/24/05 | 324.7 | -3.02% | 8 166 |
| 02/24/02 | 334.8 | +8.77% | 33,953 |
| 01/24/01 | 307.8 | -0.06% | 7,743 |
| 30/24/30 | 308 | -2.59% | 7,823 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 05, 2024 at 01:36 pm IST
More quotes
Pulsenmore Ltd is an Israel-based medical equipment company. The Company engaged in the field of research and development activity, production, marketing and sales worldwide of solutions and technologies that concern portable ultrasound devices for home use by the patient for a remote physical examination or monitoring using telehealth technology. he company has developed and sells two miniaturized ultrasound systems: the first is called PulseNmore ES, for performing home ultrasound tests for pregnant women; and the second is called PulseNmore FC, for performing a self-test of the size of the follicles in women who are in the process in vitro fertilization. Both systems make use of a smart mobile phone and make the test accessible without the need o visit in clinic or hospital, while being able to transfer film for the doctor, the treating medical team or the hotline online. Moreover the COmpany delivers software for its products.
| 1st Jan change | Capi. | |
|---|---|---|
| -54.32% | 45.03M | |
| -4.07% | 3.19B | |
| -5.53% | 170M | |
| -14.17% | 84.67M | |
| +31.88% | 61.22M |
- Stock Market
- Equities
- PULS Stock
